Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Music
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/35/96/ba/3596baa9-83b2-ae1f-83d7-75f732b3dc49/mza_14002213919152191084.jpg/600x600bb.jpg
Non-binding Guidance
Ropes & Gray LLP
37 episodes
1 month ago
A Ropes & Gray (RopesTalk) podcast series, focused on current trends in FDA regulatory law, as well as other important developments affecting the life sciences industry.
Show more...
Business News
News,
Government
RSS
All content for Non-binding Guidance is the property of Ropes & Gray LLP and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A Ropes & Gray (RopesTalk) podcast series, focused on current trends in FDA regulatory law, as well as other important developments affecting the life sciences industry.
Show more...
Business News
News,
Government
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/35/96/ba/3596baa9-83b2-ae1f-83d7-75f732b3dc49/mza_14002213919152191084.jpg/600x600bb.jpg
The Demise of Chevron and Implications for Future APA Challenges
Non-binding Guidance
37 minutes
1 year ago
The Demise of Chevron and Implications for Future APA Challenges

On this episode of Ropes & Gray’s podcast series, Non-binding Guidance, life sciences regulatory and compliance partner Greg Levine and counsel Beth Weinman are joined by appellate and Supreme Court practice head Doug Hallward-Driemeier to explore the Supreme Court's recent landmark decision in Loper Bright, which ended the long-standing practice of Chevron deference. Learn how this ruling has reshaped the regulatory landscape for federal agencies like the FDA and what it means for companies navigating these changes, including implications for Administrative Procedure Act (APA) challenges going forward. 

Non-binding Guidance
A Ropes & Gray (RopesTalk) podcast series, focused on current trends in FDA regulatory law, as well as other important developments affecting the life sciences industry.